Noticias de BIIB_US
Noticias del mercado
Últimas noticias sobre BIIB_US — 455 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Biogen sigue siendo el centro de atención de los analistas después de que Needham reiteró su calificación de compra para la biotecnología que cotiza en Nasdaq.
Bronstein, Gewirtz & Grossman, LLC Encourages Biogen Inc. (BIIB) Stockholders to Inquire about Securities Investigation
Biogen Inc at Bank of America Global Healthcare Conference Transcript
ICICI Prudential Asset Management Co Ltd redujo sus tenencias de acciones de Biogen Inc. (NASDAQ:BIIB - Informe gratuito) en un 56,4% en el cuarto trimestre, según su presentación más reciente ante la SEC. El fondo poseía 9.462 acciones de la biotecnológica
FMR LLC's Strategic Acquisition of Biogen Inc Shares
Biogen Inc. (BIIB) Announces Results of 2026 Annual Meeting of S
Biogen Inc. (BIIB) Announces Results of 2026 Annual Meeting of S
Biogen Inc. (BIIB) tops Q1 earnings and revenue estimates
Biogen (NASDAQ: BIIB) director granted 1,505-share equity compensation award
Biogen (BIIB) director receives 1,505 restricted stock units in grant
Biogen (NASDAQ: BIIB) grants director 1,505 RSUs vesting by 2026
Biogen (NASDAQ: BIIB) director Jesus B. Mantas awarded 1,505-share stock grant
[Form 4] BIOGEN INC. Insider Trading Activity
Biogen (NASDAQ: BIIB) awards 1,505 RSUs to company director
Biogen (BIIB) director Menelas Pangalos receives stock grant and exercises 2,370 RSUs
Biogen (BIIB) director Lloyd Minor receives 1,505-share equity award in Form 4 filing
Biogen beats estimates as Alzheimer’s drug gains momentum
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Invest
Biogen (NASDAQ: BIIB) director receives 2,005 restricted stock unit award
Biogen Inc. stock outperforms competitors on strong trading day
Página 1 de 23
